Profitelligence Profitelligence · Filing Ledger Open A research →

Form 8-K · Current Report · Filed 2026-02-25

Agilent Technologies Reports Q1 FY2026 Results, Raises Full-Year Guidance

Agilent Technologies, Inc. reported solid financial results for the first quarter of fiscal year 2026, with revenue of $1.80 billion, a 7.0% increase from the first quarter of 2025. The company reported GAAP net income of $305 million, or $1.07 per share, and non-GAAP net income of $386 million, or $1.36 per share, up 4% from the prior year quarter. The company also raised its full-year revenue outlook and increased its non-GAAP EPS guidance, while confirming core revenue growth and margin expansion for the full year.

Filer
Agilent Technologies Inc. A · NYSE
Filed
Accession
0001090872-26-000015
CIK
0001090872
Signal
High impactHealthcare

Items reported

Item events

Reported Item

Earnings Beat Raised Guidance

Market reaction

Close before filing

$124.40

Next session

-2.8%

Since filing

+11.2%

Latest close

$138.37

What happened, not what will happen — closing prices around the filing date.

About Agilent Technologies Inc.

Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another A filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts